The 13th Antibody Industrial Symposium 2025 (AIS2025) is a prestigious international congress jointly organized by the scientific society LabEx MAbImprove and the dynamic biotherapy industrial organization MabDesign. This event covers the latest advances and associated challenges in the field of therapeutic antibodies and their derivatives, recombinant proteins and other biomedicines, from R&D and into clinical phases.
This symposium isn’t just another conference; it’s a vibrant platform where researchers, industry leaders, medical professionals, and policymakers converge to explore the latest advancements in therapeutic antibodies and beyond. It features captivating keynote lectures, dynamic pitch talks unveiling innovative projects, and insightful industry presentations from leading pharmaceutical entities.
Spanning across 11 insightful sessions, this year’s program will explore the hottest trends in antibody research and development, encompassing areas such as Discovery and optimization of Ms/Bs Abs, Immunocytokines, and Next-Gen anti-PD-1, AI-based computational approaches, Biomarker assay development for ADC selection, Fc domains of mAbs, ADCs, BsAbs and Fc-fusion proteins : Potency, Safety, Regulatory & IP to name a few.
The program will allow plenty of opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.
Register HERE
